Breathe
Scope & Guideline
Connecting minds for a healthier breath.
Introduction
Aims and Scopes
- Clinical Management of Respiratory Diseases:
The journal covers a wide array of respiratory conditions, including asthma, COPD, lung cancer, and tuberculosis, providing insights into their diagnosis, treatment, and management. - Multidisciplinary Approaches:
Emphasizing the importance of collaboration among various healthcare professionals, 'Breathe' explores how interdisciplinary teams can enhance patient care and outcomes in respiratory medicine. - Innovations in Diagnostic and Therapeutic Techniques:
The journal highlights advancements in medical technology and treatment methodologies, including imaging techniques, bronchoscopy, and novel therapeutic agents. - Patient-Centered Care:
'Breathe' focuses on patient experiences and outcomes, advocating for the inclusion of patient perspectives in treatment decisions and research. - Research and Evidence-Based Practices:
The journal publishes reviews, original research, and guidelines that contribute to the evidence base for clinical practices in respiratory medicine. - Public Health and Respiratory Disease Prevention:
It addresses the broader implications of respiratory diseases, including their prevention, epidemiology, and the impact of environmental factors on lung health.
Trending and Emerging
- Personalized Medicine and Treatable Traits:
There is a growing emphasis on personalized approaches to treatment, particularly in asthma and COPD, where understanding individual patient characteristics can lead to more effective management strategies. - Impact of Environmental Factors on Respiratory Health:
Recent publications are increasingly addressing the influence of climate change, air quality, and environmental exposures on respiratory diseases, highlighting the need for public health initiatives. - Integration of Technology in Respiratory Care:
The use of telemedicine, digital health applications, and artificial intelligence in diagnosing and managing respiratory diseases is becoming a prominent theme, reflecting advancements in healthcare delivery. - Chronic Respiratory Disease Management in Special Populations:
Emerging research focuses on tailored management strategies for special populations, including children, the elderly, and individuals with comorbidities, emphasizing the need for targeted interventions. - Patient Involvement and Experience:
There is a strong trend towards incorporating patient feedback and involvement in research, with studies focusing on patient-reported outcomes and shared decision-making in treatment plans. - Advanced Imaging Techniques:
The journal is highlighting advancements in imaging technologies, such as multimodal imaging and artificial intelligence applications in radiology, which are enhancing diagnostic capabilities.
Declining or Waning
- Basic Science Research:
While foundational research is critical, there has been a noticeable decline in basic science studies related to respiratory physiology, with more emphasis shifting towards clinical applications and patient-centered research. - Single-Disease Focus:
The journal's earlier issues often focused on specific diseases in isolation. However, there is a decreasing trend in single-disease studies as the focus shifts toward the complexities of comorbidities and integrated care. - Historical Perspectives on Respiratory Diseases:
Papers that explore historical cases or the evolution of treatment methods are becoming less common, indicating a shift towards contemporary issues and future directions in research. - Traditional Epidemiological Studies:
There has been a decline in purely descriptive epidemiological studies, as the journal increasingly emphasizes intervention studies and clinical outcomes. - Pharmacological Studies without Clinical Context:
Research focusing solely on pharmacological agents, without linking them to clinical outcomes or patient experiences, is seeing reduced attention in favor of more comprehensive approaches.
Similar Journals
Multidisciplinary Respiratory Medicine
Elevating knowledge and practice in pulmonary medicine.Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.
RESPIRATORY RESEARCH
Bridging Research and Clinical Excellence in Respiratory CareRESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.
Tuberculosis and Respiratory Diseases
Connecting researchers in the fight against tuberculosis.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
Pulmonology
Exploring the frontiers of respiratory health and innovation.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
REVUE DES MALADIES RESPIRATOIRES
Enhancing understanding of respiratory diseases since 1984.REVUE DES MALADIES RESPIRATOIRES is a distinguished journal published by MASSON EDITEUR, focusing on the vital field of pulmonary and respiratory medicine. Established in 1984, this journal has become a prominent platform for sharing innovative research and clinical findings, reflecting an impressive array of studies that contribute to our understanding of respiratory diseases. With its ISSN 0761-8425 and E-ISSN 1776-2588, it facilitates access to scholarly work within the medical community, although it currently operates under a subscription model rather than Open Access. As indicated by its quartile ranking of Q4 in 2023 within its category and a Scopus rank of #128/155, REVUE DES MALADIES RESPIRATOIRES serves as an essential resource for researchers, professionals, and students aiming to stay informed about advancements in respiratory health. This journal plays a crucial role in fostering discussions that drive innovation and best practices in the treatment and understanding of respiratory conditions.
Respiratory Medicine and Research
Pioneering insights in pulmonary care.Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.
LUNG
Exploring the complexities of lung diseases for better patient outcomes.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
Tuberkuloz ve Toraks-Tuberculosis and Thorax
Advancing research in respiratory health.Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.
Indian Journal of Respiratory Care
Connecting Experts to Transform Respiratory CareWelcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.
Lancet Respiratory Medicine
Shaping the future of respiratory health with impactful research.The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.